SMP0058732
View Pathway
|
Histapyrrodine H1-Antihistamine Action
Homo sapiens
Matched Description: with the agonist action of histamine at the H1 receptor and are administered to attenuate … inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation … and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … further histamine release. First-generation antihistamines readily cross the blood-brain barrier and
|
SMP0057585
View Pathway
|
Chloropyramine H1-Antihistamine Action
Homo sapiens
Matched Description: with the agonist action of histamine at the H1 receptor and are administered to attenuate … inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation … and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … further histamine release. First-generation antihistamines readily cross the blood-brain barrier and
|
SMP0059716
View Pathway
|
Isothipendyl H1-Antihistamine Action
Homo sapiens
Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and … the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … further histamine release. First-generation antihistamines readily cross the blood-brain barrier and
|
SMP0175124
View Pathway
|
Desloratadine H1-Antihistamine Immune Response Action Pathway
Homo sapiens
Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and … the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … further histamine release. First-generation antihistamines readily cross the blood-brain barrier and
|
SMP0175122
View Pathway
|
Loratadine H1-Antihistamine Immune Response Action Pathway
Homo sapiens
Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the … expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause
|
SMP0175078
View Pathway
|
Azatadine H1-Antihistamine Immune Response Action Pathway
Homo sapiens
Matched Description: at the H1 receptor and are administered to attenuate inflammatory process in order to treat … conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. Reducing the activity of the NF … -κB immune response transcription factor through the phospholipase C and the phosphatidylinositol … (PIP2) signalling pathways also decreases antigen presentation and the expression of pro-inflammatory … cytokines, cell adhesion molecules, and chemotactic factors. Furthermore, lowering calcium ion
|
SMP0175073
View Pathway
|
Dexbrompheniramine H1-Antihistamine Immune Response Action Pathway
Homo sapiens
Matched Description: with the agonist action of histamine at the H1 receptor and are administered to attenuate … inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation … and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … and cause sedation and other adverse central nervous system (CNS) effects (e.g. nervousness and
|
SMP0401755
View Pathway
|
NAD Salvage
Bacteroides clarus YIT 12056
Matched Description: NAD molecules have a relatively short half-life. NAD can be degraded by enzymes, and the degraded … degraded NAD products such as nicotinamide and nicotinamide D-ribonucleotide. NAD salvage cycles can … release of hydrogen ion, AMP and beta-nicotinamide D-ribonucleotide. This enzyme can either interact … spontaneously with water resulting in the release of D-ribofuranose 5-phosphate, hydrogen ion and … amidohydrolase resulting in ammonium, and Nicotinate beta-D-ribonucleotide. Also it can interact with
|
SMP0401822
View Pathway
|
NAD Salvage
Bacteroides xylanisolvens XB1A
Matched Description: NAD molecules have a relatively short half-life. NAD can be degraded by enzymes, and the degraded … degraded NAD products such as nicotinamide and nicotinamide D-ribonucleotide. NAD salvage cycles can … release of hydrogen ion, AMP and beta-nicotinamide D-ribonucleotide. This enzyme can either interact … spontaneously with water resulting in the release of D-ribofuranose 5-phosphate, hydrogen ion and … amidohydrolase resulting in ammonium, and Nicotinate beta-D-ribonucleotide. Also it can interact with
|
SMP0402239
View Pathway
|
NAD Salvage
Bartonella quintana str. Toulouse
Matched Description: NAD molecules have a relatively short half-life. NAD can be degraded by enzymes, and the degraded … degraded NAD products such as nicotinamide and nicotinamide D-ribonucleotide. NAD salvage cycles can … release of hydrogen ion, AMP and beta-nicotinamide D-ribonucleotide. This enzyme can either interact … spontaneously with water resulting in the release of D-ribofuranose 5-phosphate, hydrogen ion and … amidohydrolase resulting in ammonium, and Nicotinate beta-D-ribonucleotide. Also it can interact with
|